| (1) |
Burch HB, Wartofsky L. Graves' ophthalmopathy: current
concepts regarding pathogenesis and management. Endocr Rev 1993; 14: 747-93. |
| (2) |
Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout
A, van der Gaag R. Effect of abnormal thyroid function on the severity of
Graves' ophthalmopathy. Arch Intern Med 1990; 150: 1098-101. |
| (3) |
Sridama V, DeGroot LJ. Treatment of Gravesﾍ disease
and the course of ophthalmopathy. Am J Med 1989; 87: 70-3. |
| (4) |
Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G,
Pinchera A. Relationship between Graves' ophthalmopathy and type of treatment
of Graves' hyperthyroidism. Thyroid 1992; 2: 171-8. |
| (5) |
Winsa B, Rastad J, Akerstrom G, Johansson H, Westermark
K, Karlsson FA. Retrospective evaluation of subtotal and total thyroidectomy
in Graves' disease with and without endocrine ophthalmopathy. Eur J Endocrinol
1995; 132: 406-12. |
| (6) |
Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri
A, Pinchera A. Use of corticosteroids to prevent progression of Graves'
ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med
1989; 321: 1349-52. |
| (7) |
Mourits MP, Koornneef L, Wiersinga WM, Prummel MP, Berghout
A, van der Gaag R. Clinical criteria for the assessment of disease activity
in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 1989; 73: 639-44. |
| (8) |
Gwinup G, Elias AN, Ascher MS. Effect on exophthalmos
of various methods of treatment of Graves' disease. JAMA 1982; 247: 2135-8. |
| (9) |
Calissendorff BM, Soderstrom M, Alveryd A. Ophthalmopathy
and hyperthyroidism: a comparison between patients receiving different antithyroid
treatments. Acta Ophthalmol (Copenh) 1986; 64: 698-703. |
| (10) |
Vasquez-Chavez C, Nishimura Meguro E, Espinosa Said
L, DelgadoFalfari A, Sainz de Viteri M. Influencia del tratamiento del hipertiroidismo
en el curso del exoftalmos. Rev Invest Clin 1992; 44: 241-7. |
| (11) |
Fernandez Sanchez JR, Rosell Pradas J, Carazo Martinez
O, et al. Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine
therapy. Br J Surg 1993; 80: 1134-6. |
| (12) |
Bartley GB, Fatourechi V, Kadrmas EF, et al. Chronology
of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;
121: 426-34. |
| (13) |
Tallstedt L, Lundell G, Tﾀrring O, et al. Occurrence
of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J
Med 1992; 326: 1733-8. |
| (14) |
Kung AWC, Yau CC, Cheng A. The incidence of ophthalmopathy
after radioiodine therapy for Graves' disease: prognostic factors and the
role of methimazole. J Clin Endocrinol Metab 1994; 79: 542-6. |
| (15) |
Vestergaard H, Laurberg P. Radioiodine and aggravation
of Graves' ophthalmopathy. Lancet 1989; 2: 47. |
| (16) |
Karlsson FA, Westermark K, Dahlberg PA, Jansson R, Enoksson
P. Ophthalmopathy and thyroid stimulation. Lancet 1989; 2: 691. |
| (17) |
Barth A, Probst P, Burgi H. Identification of a subgroup
of Gravesﾍ disease patients at higher risk for severe ophthalmopathy after
radioiodine. J Endocrinol Invest 1991; 14: 209-12. |
| (18) |
Hetzel BS, Mason EK, Wang HK. Studies of serum long-acting
thyroid stimulator (LATS) in relation to exophthalmos after therapy for
thyrotoxicosis. Australas Ann Med 1968; 17: 307-11. |
| (19) |
Aron-Rosa D, Pﾓrez R, Abitbol Y. Malignant exophthalmos
after iodine-131 treatment. Mod Probl Ophthalmol 1973; 14: 432-4. |
| (20) |
Wasnich RD, Grumet FC, Payne RO, Kriss JP. Gravesﾍ ophthalmopathy
following external neck irradiation for nonthyroidal neoplastic disease.
J Clin Endocrinol Metab 1973; 37: 703-13. |
| (21) |
Jackson R, Rosenberg C, Kleinmann R, Vagenakis AG, Braverman
LE. Ophthalmopathy after neck irradiation therapy for Hodgkinﾍs disease.
Cancer Treat Rep 1979; 63: 1393-5. |
| (22) |
Bartalena L, Bogazzi F, Pecori F, Martino E. Gravesﾍ
disease occurring after subacute thyroiditis: report of a case and review
of the literature. Thyroid 1996; 6: 345-8. |
| (23) |
Tallstedt L, Lundell G, Blomgren H, Bring J. Does early
administration of thyroxine reduce the development of Gravesﾍ ophthalmopathy
after radioiodine treatment? Eur J Endocrinol 1994; 130: 494-7. |
| (24) |
Bartalena L, Martino E, Marcocci C, et al. More on smoking
habits and Graves' ophthalmopathy. J Endocrinol Invest 1989; 12: 733-7. |
| (25) |
Bartalena L, Bogazzi F, Tanda ML, Manetti L, DellﾍUnto
E, Martino E. Cigarette smoking and the thyroid. Eur J Endocrinol 1995;
133: 507-12 |
| (26) |
Wiersinga WM, Prummel MF. Retrobulbar radiation in Graves'
ophthalmopathy. J Clin Endocrinol Metab 1995; 80: 345-7. |
| (27) |
Marcocci C, Gianchecchi D, Masini I, et al. A reappraisal
of the role of methimazole and other factors on the efficacy and outcome
of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 1990;
13: 513-20. |
| (28) |
Vitti P, Rago T, Chiovato L, et al. Clinical features
of patients with Graves' disease undergoing remission after antithyroid
drug treatment. Thyroid 1997; 7: 369-75. |